Organization
Novartis AG
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Novartis AG
... get global rights to anything found by the alliance. ( Endpoints ) Novartis has promoted Sreejit Mohan from global drug-development communications leader to global head ...
... Abbott Medical Optics, Carl Zeiss Meditec AG, Bausch & Lomb, Inc., Alcon (Novartis AG), Calhoun Vision, Inc.,Staar Surgical Company ,Hoya Surgical Optics, Rayner Intraocular Lenses ...
... Rebuilding Novartis' reputation is a top priority for CEO Vas Narasimhanafter a series of ...
... change the company's R&D leadership,” he wrote in a note to clients. RELATED:Novartis poaches Pfizer veteran Liz Barrett to lead cancer unit—and its big Kymriah ...
... week. CellectisStefan Scherer, M.D., Ph.D.,was named SVP of clinical development. Scherer was Novartis' head of early development, strategy and innovation for its U.S. oncology arm.France's ...
... - Pfizer - Eisai - Actavis - Lundbeck - Daiichi Sankyo - Novartis - TauRx - vTv Therapeutics - Profiles of leading companies developing diagnostics ...
... Swiss pharmaceutical company Novartis AG signed a virtual power purchase agreement with Invenergy LLC for 100 ...
... product royalties from sales of Jakavi (ruxolitinib), which has been out-licensed to Novartis outside of the United States, were $ 47 million and $ 88 ...
... a high priority on innovation and portfolio expansion (Kim, 2018).Along these lines, Novartis has acquired AveXis, the developer of AVXS-101, which treats spinal muscular atrophy, ...
... vaccines, while the EH segment markets branded generics, biosimilars and select branded pNovartis Novartis - $49bn Novartis reported 1% year-on-year increase in revenues in 2017, ...
Subscribe now for full coverage on Novartis AG
Start My Free Trial